| 000 | 01261 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250517061310.0 | ||
| 264 | 0 | _c20160706 | |
| 008 | 201607s 0 0 eng d | ||
| 022 | _a1750-1172 | ||
| 024 | 7 |
_a10.1186/s13023-015-0349-z _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWinstone, Julie | |
| 245 | 0 | 0 |
_aReview and comparison of clinical evidence submitted to support European Medicines Agency market authorization of orphan-designated oncological treatments. _h[electronic resource] |
| 260 |
_bOrphanet journal of rare diseases _cOct 2015 |
||
| 300 |
_a139 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xeconomics |
| 650 | 0 | 4 |
_aClinical Trials as Topic _xeconomics |
| 650 | 0 | 4 |
_aDrug Approval _xeconomics |
| 650 | 0 | 4 | _aEurope |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aOrphan Drug Production _xeconomics |
| 650 | 0 | 4 |
_aRare Diseases _xdrug therapy |
| 700 | 1 | _aChadda, Shkun | |
| 700 | 1 | _aRalston, Stephen | |
| 700 | 1 | _aSajosi, Peter | |
| 773 | 0 |
_tOrphanet journal of rare diseases _gvol. 10 _gp. 139 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s13023-015-0349-z _zAvailable from publisher's website |
| 999 |
_c25396589 _d25396589 |
||